Lipocine (LPCN) Shares Outstanding (Diluted) (2012 - 2025)
Lipocine (LPCN) posted Shares Outstanding (Diluted) of 5.41 million for Q4 2025, down 0.2% from 5.42 million a year earlier and unchanged from the prior quarter.
Powered by 
Analysis
Lipocine (LPCN) Shares Outstanding (Diluted) (2012 - 2025) Analysis & Trends
Since Q4 2012, Lipocine has reported Shares Outstanding (Diluted) for 53 quarters.
- Annual Shares Outstanding (Diluted) shows a five-year compound annual growth rate of 10.6% (FY2020 to FY2025).
- In prior years, Lipocine's Shares Outstanding (Diluted) was 5.42 million in FY2024 (+2.9%), 5.27 million in FY2023 (+0.8%), 5.23 million in FY2022 (+2.2%) and 5.11 million in FY2021 (+56.1%).
- Quarterly Shares Outstanding (Diluted) has run from a low of 4.82 million in Q1 2021 to a high of 5.42 million in Q4 2024 over five years.
- On a year-over-year basis, Shares Outstanding (Diluted) increased in six of the last eight quarters, with growth averaging 1.2%.
- The strongest year-over-year quarter for Shares Outstanding (Diluted) in the past five years was Q1 2021, with growth of 98.0%; the weakest was Q4 2025, with a decline of 0.2%.
- According to Business Quant data, Shares Outstanding (Diluted) for the three prior quarters was 5.41 million (Q3 2025), 5.35 million (Q2 2025) and 5.35 million (Q1 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Dil.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 2.44 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 1.77 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 2.47 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 1.96 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 1.56 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 544.00 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 1.24 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 5.70 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 255.20 Mn |
| 10 | Lipocine | 11.92 Mn | -55.79 Mn | - | 5.41 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 5.41 Mn |
| Sep 30, 2025 | 5.41 Mn |
| Jun 30, 2025 | 5.35 Mn |
| Mar 31, 2025 | 5.35 Mn |
| Dec 31, 2024 | 5.42 Mn |
| Sep 30, 2024 | 5.35 Mn |
| Jun 30, 2024 | 5.34 Mn |
| Mar 31, 2024 | 5.36 Mn |
| Dec 31, 2023 | 5.27 Mn |
| Sep 30, 2023 | 5.29 Mn |
| Jun 30, 2023 | 5.23 Mn |
| Mar 31, 2023 | 5.21 Mn |
| Dec 31, 2022 | 5.23 Mn |
| Sep 30, 2022 | 5.22 Mn |
| Jun 30, 2022 | 5.23 Mn |
| Mar 31, 2022 | 5.19 Mn |
| Dec 31, 2021 | 5.11 Mn |
| Sep 30, 2021 | 5.19 Mn |
| Jun 30, 2021 | 5.19 Mn |
| Mar 31, 2021 | 4.82 Mn |
API Access
Lipocine Shares Outstanding (Diluted) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=LPCN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "shares-outstanding-diluted", "ticker": "LPCN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=LPCN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();